Artículos científicos Open Access
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
The Lancet
Miquel Oliu-Barton, et al
From lockdown to vaccines: challenges and response in Nepal during the COVID-19 pandemic
The Lancet Respiratory Medicine
Sajog Kansakar, et al
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study
The Lancet Diabetes & Endocrinology
Min Gao, et al
New insights into the association between body-mass index and severe COVID-19
The Lancet Diabetes & Endocrinology
Krishnan Bhaskaran
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
The Lancet Rheumatology
David Saadoun, et al
COVID-19 in patients with rheumatic disease: finally, a denominator
The Lancet Rheumatology
Daniel J Wallace
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
The Lancet Oncology
Leticia Monin, et al
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
The Lancet Infectious Diseases
Cristina Menni, et al
Symptom study app provides real-world data on COVID-19 vaccines
The Lancet Infectious Diseases
Ruth E Drury, Daniel O'Connor
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
The Lancet Haematology
Federico Angriman, et al
Correction to Lancet Respir Med 2021; published online April 19. https://doi.org/10.1016/S2213-2600(21)00096-5
The Lancet Respiratory Medicine
